An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.
A Review of Reports of Lymphoma Occurring in Patients With Rheumatoid Arthritis or Crohn's Disease in Centocor-Sponsored and Centocor-Supported Disease Registries
2 other identifiers
observational
120
1 country
3
Brief Summary
The purpose of this study is to examine the association with EBV infection, monitor the occurrence of lymphoma and assess lymphoma risk in patients with rheumatoid arthritis and/or Crohns disease and you have taken infliximab.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2006
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 26, 2007
CompletedFirst Posted
Study publicly available on registry
February 27, 2007
CompletedApril 10, 2014
April 1, 2014
6 months
February 26, 2007
April 9, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of lymphoma
To examine the occurrence of lymphoma among patients in one Centocor-sponsored and Centocor-supported disease registries
5 years
Secondary Outcomes (2)
Assessment of lymphoma risk
5 years
Evaluation of association of Epstein-Barr Virus (EBV) with the lymphoma
5 years
Study Arms (1)
Patients with lymphoma
Lymphoma Occurring in Patients with Rheumatoid Arthritis or Crohn's Disease
Interventions
All treatments are prescribed by a physician on the basis of usual clinical practice.
Eligibility Criteria
You may qualify if:
- Patients with Crohns disease or rheumatoid arthritis who participate in the specified registries will be included in the analysis. For the lymphoma analysis, patients must be recorded as having a lymphoma during their participation in one of these registries
You may not qualify if:
- Patients who do not have Crohns disease or rheumatoid arthritis and who did not participate in one of the identified registries will be excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Unknown Facility
Highland Park, Illinois, United States
Unknown Facility
Wichita, Kansas, United States
Unknown Facility
Albany, New York, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Centocor Ortho Biotech Services, L.L.C. Clinical Trial
Centocor Ortho Biotech Services, L.L.C.
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2007
First Posted
February 27, 2007
Study Start
February 1, 2006
Primary Completion
August 1, 2006
Study Completion
August 1, 2006
Last Updated
April 10, 2014
Record last verified: 2014-04